No photo of Joaquim Calado

View Scopus Profile

Joaquim Calado

MD, PhD

 https://orcid.org/0000-0002-1194-3392
  • 886 Citations
  • 12 h-Index
20042020

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Education/Academic qualification

Ciências da Saúde -Genética, Doctorate, NOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM)

Award Date: 1 Jul 2001

Ciências da Saúde - Medicina, Master, Universidade de Lisboa

Award Date: 1 Jul 1987

Fingerprint Dive into the research topics where Joaquim Calado is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 13 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output at NOVA

  • 886 Citations
  • 12 h-Index
  • 15 Article
  • 2 Review article
  • 1 Other contribution

Genetic and Clinical Predictors of Age of ESKD in Individuals With Autosomal Dominant Tubulointerstitial Kidney Disease Due to UMOD Mutations

Kidd, K., Vylet'al, P., Schaeffer, C., Olinger, E., Živná, M., Hodaňová, K., Robins, V., Johnson, E., Taylor, A., Martin, L., Izzi, C., Jorge, S. C., Calado, J., Torres, R. J., Lhotta, K., Steubl, D., Gale, D. P., Gast, C., Gombos, E., Ainsworth, H. C. & 22 others, Chen, Y. M., Almeida, J. R., de Souza, C. F., Silveira, C., Raposeiro, R., Weller, N., Conlon, P. J., Murray, S. L., Benson, K. A., Cavalleri, G. L., Votruba, M., Vrbacká, A., Amoroso, A., Gianchino, D., Caridi, G., Ghiggeri, G. M., Divers, J., Scolari, F., Devuyst, O., Rampoldi, L., Kmoch, S. & Bleyer, A. J., Sep 2020, In : Kidney International Reports. 5, 9, p. 1472-1485 14 p.

Research output: Contribution to journal › Article

Open Access
File
    • 1 Downloads (Pure)

    Efeito da empagliflozina para além do controlo glicémico: benefício cardiovascular em doentes com DMT2 e doença cardiovascular estabelecida

    Translated title of the contribution: Effect of empagliflozin beyond glycemic control: Cardiovascular benefit in patients with type 2 diabetes and established cardiovascular diseaseMonteiro, P., Aguiar, C., Matos, P., Silva‐Nunes, J., Birne, R., Branco, P., Calado, J., Melo, M. & Polónia, J., Oct 2019, In : Revista Portuguesa de Cardiologia. p. 721-735

    Research output: Contribution to journal › Review article

    • 1 Citation (Scopus)

    The Na+-coupled glucose transporter SGLT2 interacts with its accessory unit MAP17 in vitro and their expressions overlap in the renal proximal tubule

    Calado, J., Santos, A. R., Aires, I., Lebre, F., Nolasco, F., Rueff, J. & Ramalho, J., Oct 2018, In : FEBS Letters. 592, 19, p. 3317-3326

    Research output: Contribution to journal › Article

    • MAP17 Is a Necessary Activator of Renal Na+/Glucose Cotransporter SGLT2

    Coady, M. J., El Tarazi, A., Santer, R., Bissonnette, P., Sasseville, L. J., Calado, J., Lussier, Y., Dumayne, C., Bichet, D. G. & Lapointe, J-Y., Jan 2017, In : Journal Of The American Society Of Nephrology. 28, 1, p. 85-93 8 p.

    Research output: Contribution to journal › Article

    • 26 Citations (Scopus)

    Adult presentation of Bartter syndrome type IV with erythrocytosis

    Heilberg, I. P. F., Tótoli, C. & Calado, J. T. O., 1 Oct 2015, In : Einstein (São Paulo, Brazil). 13, 4, p. 604-606 3 p.

    Research output: Contribution to journal › Article

    Open Access
    File
    • 8 Citations (Scopus)
    2 Downloads (Pure)